WallStreetZen

NYSE: NVS
Novartis Ag Earnings & Revenue

NVS past earnings growth

How has NVS's earnings growth performed historically?
Company
-34.09%
Industry
13.49%
Market
77.49%
NVS's earnings have grown slower (4.19% per year) than the US Drug Manufacturers - General industry average (7.58%)
Performance
NVS's earnings have grown slower (4.19% per year) than the US market average (20.98%)
Performance
NVS's earnings growth is slowing down - its growth over the last year (-34.09%) is below its 5-year compound annual rate (4.19%)
Performance

NVS past revenue growth

How has NVS's revenue growth performed historically?
Company
-0.09%
Industry
11.58%
Market
28.71%
NVS's revenue has grown slower (-0.04% per year) than the US Drug Manufacturers - General industry average (4.72%)
Performance
NVS's revenue has grown slower (-0.04% per year) than the US market average (16.77%)
Performance
NVS's revenue growth is slowing down - its growth over the last year (-0.09%) is below its 5-year compound annual rate (-0.04%)
Performance

NVS earnings and revenue history

Current Revenue
$49.9B
Current Earnings
$8.0B
Current Profit Margin
15.9%
NVS's has not demonstrated consistent long-term earnings growth over the past 10 years (-16.67%)
Performance

NVS Return on equity

Current Company
14.8%
Current Industry
31.9%
Current Market
31.1%
NVS's Return on Equity (14.8%) shows a company that is not efficient at transforming shareholder equity into returns
Performance

NVS Return on assets

Current Company
6.3%
Current Industry
6.8%
Current Market
6.5%
NVS is generating lower Return on Assets (6.3%) than the US Drug Manufacturers - General industry average (7.04%)
Performance

NVS Return on capital employed

Current Company
11.5%
Current Industry
11.3%
NVS has gotten more efficient at generating Return on Capital (11.5%) compared to 3 years ago (9.82%)
Performance

Novartis Ag Earnings & Revenue FAQ

What were NVS's earnings last quarter?

Novartis Ag (NYSE: NVS) reported Q1 2021 earnings per share (EPS) of $0.91, up 5.21% year over year. Total Novartis Ag earnings for the quarter were $2.06 billion. In the same quarter last year, Novartis Ag's earnings per share (EPS) was $0.96.

What was NVS's earnings growth in the past year?

As of Q2 2021, Novartis Ag's earnings has grown -34.09% year over year. This is 47.58 percentage points lower than the US Drug Manufacturers - General industry earnings growth rate of 13.49%. Novartis Ag's earnings in the past year totalled $7.96 billion.

What was NVS's revenue last quarter?

Novartis Ag (NYSE: NVS) reported Q1 2021 revenue of $12.69 billion up 0.11% year over year. In the same quarter last year, Novartis Ag's revenue was $12.71 billion.

What was NVS's revenue growth in the past year?

As of Q2 2021, Novartis Ag's revenue has grown -0.09% year over year. This is 11.68 percentage points lower than the US Drug Manufacturers - General industry revenue growth rate of 11.58%. Novartis Ag's revenue in the past year totalled $49.88 billion.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.